Immutep Limited engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer.
| Market Cap | 218.911 Million | Shares Outstanding | 114.016 Million | Avg 30-day Volume | 111.611 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | |
| Price to Revenue | 46.6552 | Debt to Equity | 0.0011 | EBITDA | -22.397 Million |
| Price to Book Value | 2.338 | Operating Margin | -719.7109 | Enterprise Value | 96.713 Million |
| Current Ratio | 14.157 | EPS Growth | 0 | Quick Ratio | 13.776 |
| 1 Yr BETA | 1.073 | 52-week High/Low | 3.9 / 1.47 | Profit Margin | -683.2491 |
| Operating Cash Flow Growth | -57.498 | Free Cash Flow to Firm (FCFF) TTM | -15.263 Million | Free Cash Flow to Equity (FCFE) TTM | -16.262 Million |
| Altman Z-Score | 12.1552 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 22:15:05 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 21:45:03 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 21:15:04 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 20:45:04 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 20:15:05 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 19:45:03 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 19:15:04 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 18:45:04 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 18:15:04 UTC | -1.0498 | 6.3698 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 17:45:03 UTC | 0.0 | 0.0 | 750000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 17:15:03 UTC | 0.0 | 0.0 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 16:45:04 UTC | -0.9438 | 6.2638 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 16:15:05 UTC | -0.9438 | 6.2638 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 15:45:04 UTC | -0.9438 | 6.2638 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 15:15:03 UTC | -0.9438 | 6.2638 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 14:45:03 UTC | -0.8153 | 6.1353 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 14:15:03 UTC | -0.8153 | 6.1353 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 13:45:03 UTC | -0.9717 | 6.2917 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 13:15:05 UTC | -0.9717 | 6.2917 | 800000 |
| IMMUTEP LTD-SP ADR IMMP | 2023-09-27 12:45:05 UTC | -0.9717 | 6.2917 | 800000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|---|---|---|---|
| Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | IMMP | -1500.0 shares, $-3165.0 | 2023-06-30 | N-PORT |
